Related Experiment Videos
High cholesterol levels are associated with improved long-term survival after acute ischemic stroke
Ioanna Markaki1, Ulrik Nilsson1, Konstantinos Kostulas1
1Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
Insights
High admission cholesterol levels were linked to better long-term survival after ischemic stroke (IS). This finding helps explain the cholesterol paradox in IS patients, even after accounting for statin use.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Biochemistry
Background:
- Prior statin treatment and high admission cholesterol are paradoxically linked to better outcomes post-ischemic stroke (IS).
- The exact mechanisms behind this observed paradox remain incompletely understood.
- Investigating cholesterol's role is crucial for understanding IS prognosis.
Purpose of the Study:
- To examine the impact of admission cholesterol levels on short- and long-term survival following IS.
- To evaluate the influence of prior statin treatment on IS outcomes.
- To clarify the relationship between cholesterol and mortality risk in IS patients.
Main Methods:
- Analysis of consecutive IS patients admitted in 2006 and 2010.
- Definition of high total cholesterol as ≥ 4.6 mmol/L.
- Logistic and Cox regression analyses for 1-month and long-term mortality prediction, respectively.
Main Results:
- Low cholesterol levels were associated with older age, lower blood pressure, and angina.
- Patients with high admission cholesterol demonstrated significantly better 1-, 5-, and 7-year survival rates compared to those with low cholesterol (P=.0001).
- Low cholesterol independently predicted increased mortality risk (adjusted hazard ratio: 1.87; 95% CI: .94-3.32).
Conclusions:
- High admission cholesterol may be associated with improved long-term survival after ischemic stroke.
- Further research into the dynamic changes of cholesterol levels and their correlation with stroke outcomes is warranted.
- These findings contribute to resolving the cholesterol paradox in IS.
Background:
Prior statin treatment and high admission cholesterol have been associated with favorable outcome after ischemic stroke (IS), a paradox not completely explained. The aim of this study was to investigate the effect of admission cholesterol levels and the impact of statin treatment on short- and long-term survival after IS.
Methods:
Consecutive patients admitted in 2006 and 2010 were included in the study. Total cholesterol of 4.6 mmol/L or more was defined as high. Logistic regression analysis was performed to assess predictors of 1-month mortality, and Cox proportional hazard regression analysis was applied to investigate predictors of long-term mortality.
Results:
Of 190 patients included in the final analysis, 21 (11%) died within 1 month and 61 (32%) died during 7 years of observation. Low cholesterol was associated with older age, lower blood pressure (BP), presence of angina, and higher risk of death. Three-month, 1-year, and 5-year survival rates were 100%, 98%, and 84%, respectively, in high cholesterol patients, compared with 92%, 87%, and 57% in low cholesterol group (P = .0001 with the log-rank test). Mortality risk was increased for patients with low cholesterol (hazard ratio: 1.97; 95% confidence interval [CI]: 1.05-3.69), after adjustment for age and admission National Institutes of Health Stroke Scale score. After further adjustment for angina and admission BP, the effect of cholesterol on mortality risk was still obvious, yet attenuated (hazard ratio: 1.87; 95% CI: .94-3.32).
Conclusions:
High admission cholesterol may be associated with increased long-term survival after IS. Future studies on the temporal profile of cholesterol levels and stroke outcome would be of interest.
Related Concept Videos
Atherosclerosis III: Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Ischemic Stroke l: Introduction
Atherosclerosis IV: Nursing Management
Ischemic Stroke ll: Pathophysiology